Antimalarial drug discovery: From quinine to the dream of eradication

ACS Medicinal Chemistry Letters

Volumn 4, Issue 12, 2013, Pages 1126-1128

  Renslo, Adam R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CINCHONA BARK; DSM 265; ELQ 300; GNF 156; OZ 439; PLANT MEDICINAL PRODUCT; TAFENOQUINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTEMISIA ANNUA; BARK; CHINESE MEDICINE; CINCHONA; DISEASE TRANSMISSION; FEVER; HERBAL MEDICINE; HUMAN; MALARIA FALCIPARUM; PRIORITY JOURNAL; REVIEW;

EID: 84890449159     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml4004414     Document Type: Review

References (9)

1. Greenwood, D. The quinine connection J. Antimicrob. Chemother. 1992, 30, 417-427
2. Faurant, C. From bark to weed: The history of artemisinin Parasite 2011, 18, 215-218
3. Coteron, J. M.; Catterick, D.; Castro, J.; Chaparro, M. J.; Diaz, B.; Fernandez, E.; Ferrer, S.; Gamo, F. J.; Gordo, M.; Gut, J.; de las Heras, L.; Legac, J.; Marco, M.; Miguel, J.; Munoz, V.; Porras, E.; de la Rosa, J. C.; Ruiz, J. R.; Sandoval, E.; Ventosa, P.; Rosenthal, P. J.; Fiandor, J. M. Falcipain inhibitors: Optimization studies of the 2-pyrimidinecarbonitrile lead series J. Med. Chem. 2010, 53, 6129-6152
4. Coteron, J. M.; Marco, M.; Esquivias, J.; Deng, X.; White, K. L.; White, J.; Koltun, M.; El Mazouni, F.; Kokkonda, S.; Katneni, K.; Bhamidipati, R.; Shackleford, D. M.; Angulo-Barturen, I.; Ferrer, S. B.; Jimenez-Diaz, M. B.; Gamo, F. J.; Goldsmith, E. J.; Charman, W. N.; Bathurst, I.; Floyd, D.; Matthews, D.; Burrows, J. N.; Rathod, P. K.; Charman, S. A.; Phillips, M. A. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential J. Med. Chem. 2011, 54, 5540-5561
5. Nilsen, A.; LaCrue, A. N.; White, K. L.; Forquer, I. P.; Cross, R. M.; Marfurt, J.; Mather, M. W.; Delves, M. J.; Shackleford, D. M.; Saenz, F. E.; Morrisey, J. M.; Steuten, J.; Mutka, T.; Li, Y.; Wirjanata, G.; Ryan, E.; Duffy, S.; Kelly, J. X.; Sebayang, B. F.; Zeeman, A. M.; Noviyanti, R.; Sinden, R. E.; Kocken, C. H.; Price, R. N.; Avery, V. M.; Angulo-Barturen, I.; Jimenez-Diaz, M. B.; Ferrer, S.; Herreros, E.; Sanz, L. M.; Gamo, F. J.; Bathurst, I.; Burrows, J. N.; Siegl, P.; Guy, R. K.; Winter, R. W.; Vaidya, A. B.; Charman, S. A.; Kyle, D. E.; Manetsch, R.; Riscoe, M. K. Quinolone-3-diarylethers: A new class of antimalarial drug Sci. Transl. Med. 2013, 5, 177ra37
6. Charman, S. A.; Arbe-Barnes, S.; Bathurst, I. C.; Brun, R.; Campbell, M.; Charman, W. N.; Chiu, F. C.; Chollet, J.; Craft, J. C.; Creek, D. J.; Dong, Y.; Matile, H.; Maurer, M.; Morizzi, J.; Nguyen, T.; Papastogiannidis, P.; Scheurer, C.; Shackleford, D. M.; Sriraghavan, K.; Stingelin, L.; Tang, Y.; Urwyler, H.; Wang, X.; White, K. L.; Wittlin, S.; Zhou, L.; Vennerstrom, J. L. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 4400-4405
7. Rottmann, M.; McNamara, C.; Yeung, B. K.; Lee, M. C.; Zou, B.; Russell, B.; Seitz, P.; Plouffe, D. M.; Dharia, N. V.; Tan, J.; Cohen, S. B.; Spencer, K. R.; Gonzalez-Paez, G. E.; Lakshminarayana, S. B.; Goh, A.; Suwanarusk, R.; Jegla, T.; Schmitt, E. K.; Beck, H. P.; Brun, R.; Nosten, F.; Renia, L.; Dartois, V.; Keller, T. H.; Fidock, D. A.; Winzeler, E. A.; Diagana, T. T. Spiroindolones, a potent compound class for the treatment of malaria Science 2010, 329, 1175-1180
8. Nagle, A.; Wu, T.; Kuhen, K.; Gagaring, K.; Borboa, R.; Francek, C.; Chen, Z.; Plouffe, D.; Lin, X.; Caldwell, C.; Ek, J.; Skolnik, S.; Liu, F.; Wang, J.; Chang, J.; Li, C.; Liu, B.; Hollenbeck, T.; Tuntland, T.; Isbell, J.; Chuan, T.; Alper, P. B.; Fischli, C.; Brun, R.; Lakshminarayana, S. B.; Rottmann, M.; Diagana, T. T.; Winzeler, E. A.; Glynne, R.; Tully, D. C.; Chatterjee, A. K. Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents J. Med. Chem. 2012, 55, 4244-4473
9. The malERA Consultative Group on Drugs. A research agenda for malaria eradication: Drugs PLoS Med. 2011, 8, e1000402